key: cord-0810715-jz73oems
authors: Fudim, Marat; Mirro, Michael; Cheng, Hao-Ming
title: Audicor Remote Patient Monitoring: FDA Breakthrough Device and Technology for Heart Failure Management
date: 2022-04-04
journal: JACC Basic Transl Sci
DOI: 10.1016/j.jacbts.2022.02.007
sha: 9e73989db00e384f22173f9b5fe90bd3beb55f21
doc_id: 810715
cord_uid: jz73oems

nan

.

A randomized control trial recently tested Audicor Figure 1E ) with a predischarge EMATc >15%, (n ¼ 85;

HR: 0.32; 95% CI: 0.16-0.65; log-rank P < 0.001).

The above studies were performed with the use of a commercially available Audicor device that adhered to the patient with standard electrodes.

The novel Audicor RPM is a hand-held device intended for at-home use in HF management ( Figures 1B and 1C) The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.

Beyond auscultation: acoustic cardiography in the diagnosis and assessment of cardiac disease

Performance of phonoelectrocardiographic left ventricular systolic time intervals and B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction

Prognostic value of acoustic cardiography in patients with chronic heart failure

Electromechanical activation time in the prediction of discharge outcomes in patients hospitalized with acute heart failure syndrome

Effect of acoustic cardiography-guided management on 1-year outcomes in patients with acute heart failure